Lymphocyte-based determination of susceptibility to malignant hyperthermia: a pilot study in swine

Anesthesiology. 2010 Oct;113(4):917-24. doi: 10.1097/ALN.0b013e3181ee2cd0.

Abstract

Background: Malignant hyperthermia susceptibility (MHS) is diagnosed by an invasive in vitro caffeine-halothane contracture test (CHCT) carried out on biopsied skeletal muscle tissue. We are presenting a novel blood test approach for malignant hyperthermia testing in a swine model. Our main aim was to determine whether adenosine production from lymphocytes after 4-chloro-m-cresol (4CmC) stimulation distinguishes homozygous swine carrying the Arg615Cys mutation in the ryanodine receptor type 1 (RyR1) gene (MHS swine) from normal swine.

Methods: Lymphocytes were isolated from arterial blood (40 ml) obtained from MHS (n = 7) and normal (n = 7) swine. Cells were suspended in Hank's balanced salt solution and treated with 4CmC (0-10 mm) at 37°C in the presence of adenosine deaminase inhibitor. After termination and purification of samples, aliquots (50 μl) were assayed for adenosine content using high performance liquid chromatography.

Results: Baseline adenosine levels before stimulating lymphocytes with 4CmC were 0.025 ± 0.004 and 0.041 ± 0.006 μm (mean ± SEM) in lymphocytes from normal and MHS swine, respectively (P = 0.125). Maximum responses were achieved at 1 mm 4CmC for both cell-line groups. Adenosine levels after stimulation with 4CmC (1 mm) were 0.185 ± 0.009 and 0.397 ± 0.038 μm in lymphocytes from normal and MHS swine, respectively (P = 0.0035). There was no overlap between adenosine levels in stimulated lymphocytes from MHS and normal swine.

Conclusion: 4CmC stimulation of porcine lymphocytes induces increased adenosine formation in MHS cells relative to those from normal swine; evaluation of adenosine formation in response to RyR1 agonists in human lymphocytes is needed.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Adenosine / metabolism
  • Adenosine Deaminase Inhibitors
  • Adenosine Triphosphate / metabolism
  • Animals
  • Calcium / metabolism
  • Calcium / pharmacology
  • Chromatography, High Pressure Liquid
  • Disease Susceptibility
  • Enzyme Inhibitors / pharmacology
  • Imidazoles / pharmacology
  • Inosine / metabolism
  • Lymphocytes / physiology*
  • Magnesium / pharmacology
  • Malignant Hyperthermia / diagnosis*
  • Muscle Relaxants, Central / pharmacology
  • Oxazoles / pharmacology
  • Oxidative Phosphorylation / drug effects
  • Pilot Projects
  • Ryanodine Receptor Calcium Release Channel / physiology
  • Sarcoplasmic Reticulum / drug effects
  • Swine
  • Uncoupling Agents / pharmacology

Substances

  • Adenosine Deaminase Inhibitors
  • Enzyme Inhibitors
  • Imidazoles
  • Muscle Relaxants, Central
  • Oxazoles
  • Ryanodine Receptor Calcium Release Channel
  • Uncoupling Agents
  • Inosine
  • azumolene
  • Adenosine Triphosphate
  • Magnesium
  • Adenosine
  • Calcium